Evidence map›Paper›PMID 40043252›Full record

ArticleACS nano2025

Molecularly Imprinted Polyaniline-Coated Cu-Zeolitic Imidazolate Framework Nanoparticles: Uricase-Mimicking "Polynanozyme" Catalyzing Uric Acid Oxidation.

Xinghua Chen, Yi Wu, Yunlong Qin, Raanan Carmieli, Inna Popov, Vitaly Gutkin, Chunhai Fan, Itamar Willner

Abstract read
In one paragraph

Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Three-Channel Electron Engineered Fe-88A@CeOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinghua ChenInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Yi WuInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Yunlong QinInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Raanan CarmieliDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0003-4418-916X
Inna PopovThe Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Vitaly GutkinThe Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Chunhai FanSchool of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0002-7171-7338
Itamar WillnerInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0001-9710-9077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the drawbacks of nanozyme catalytic functions rests in their moderate catalytic activities due to the lack of effective binding sites concentrating the reaction substrate at the nanozyme catalytic interface. Methods to concentrate the substrates at the catalytic interface are essential to improving nanozyme functions. The present study addresses this goal by designing uric acid (UA) molecular-imprinted polyaniline (PAn)-coated Cu-zeolitic imidazolate framework (Cu-ZIF) nanoparticles as superior nanozymes, "polynanozymes", catalyzing the H

Indexed as

Aniline CompoundsCopperImidazolesMetal-Organic FrameworksMolecular ImprintingNanoparticlesUrate OxidaseUric AcidCatalysisOxidation-ReductionAniline CompoundsCopperImidazolesMetal-Organic FrameworkspolyanilineUrate OxidaseUric Acidartificial enzymenanoparticle catalysisnanozymesensorsuperoxide radical anion

Identifiers

PMID40043252
PMCPMC11924329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.